Companies Like Jade Biosciences (NASDAQ:JBIO) Are In A Position To Invest In Growth [Yahoo! Finance]
Jade Biosciences (JBIO) had its price target raised by HC Wainwright from $25.00 to $35.00. They now have a "buy" rating on the stock.
Jade Biosciences (JBIO) had its price target raised by BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
Jade Biosciences (JBIO) was downgraded by Zacks Research from "hold" to "strong sell".
Jade Biosciences (JBIO) had its price target raised by Guggenheim from $17.00 to $23.00. They now have a "buy" rating on the stock.